Journal
FUNDAMENTAL & CLINICAL PHARMACOLOGY
Volume 16, Issue 2, Pages 147-156Publisher
BLACKWELL PUBLISHING LTD
DOI: 10.1046/j.1472-8206.2002.00083.x
Keywords
labelling; new chemical entities; QT interval; regulatory approval; risk/benefit; torsade de pointes
Categories
Ask authors/readers for more resources
The views expressed in this paper are those of the author and do not necessarily represent the views or the opinions of Medicines Control Agency, other regulatory authorities or any of their advisory committees.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
